can you take a glp 1 with hashimoto's GLP-1 Agonists: The Medical Revolution Beyond Weight Loss Replying to @Joan Padilla Hashimoto’s,

Clinical trials have demonstrated average weight loss of 1215% over 68 weeks with semaglutide 2.4 mg weekly

METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) Numerous studies have shown that treatment with SGLT-2 inhibitors decrease liver enzymes (107,199-203)

It promotes weight loss, increases the use of fats as an energy source so that they burn more easily, and is more effective during periods of heavy use as a sports workout

Animal studies have shown that IGF1 LR3 use can increase bone mineral density and improve bone strength parameters

Kidney In 2004, it was found that GLP-1 mediates effects on the kidney: Healthy and obese individuals treated with GLP-1 exhibited increased sodium excretion, glomerular filtration rate and urinary secretion

GHRH Receptor Activation CJC-1295 mimics your body's natural GHRH signal, telling the pituitary to produce and release growth hormone